Page last updated: 2024-10-24

retina homeostasis

Definition

Target type: biologicalprocess

A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function. [GOC:add, GOC:dph, GOC:tb, PMID:15365173, PMID:15365178]

Retina homeostasis is a complex and dynamic process that ensures the proper function and survival of the retina, the light-sensitive tissue at the back of the eye. This intricate biological process involves a delicate balance of cellular activities, including cell survival, differentiation, and renewal, as well as the precise regulation of neurotransmitter signaling, blood flow, and metabolic processes.

**Cell Survival and Renewal:**

* **Photoreceptor survival:** Photoreceptor cells, the light-detecting cells of the retina, are highly susceptible to damage from various factors, including light exposure, oxidative stress, and aging. Retinal homeostasis involves mechanisms to protect these cells from damage and promote their survival.
* **Müller glial cell support:** Müller glial cells are the primary supporting cells in the retina, providing structural and metabolic support to neurons. They play a critical role in maintaining the health and function of photoreceptors and other retinal cells.
* **Retinal pigment epithelium (RPE) function:** The RPE, a layer of pigmented cells located at the back of the retina, plays a crucial role in photoreceptor survival and function. It absorbs excess light, removes waste products from photoreceptors, and supplies them with nutrients.

**Neurotransmitter Signaling and Synaptic Transmission:**

* **Precise regulation of neurotransmitters:** The retina relies on the coordinated activity of various neurotransmitters, including glutamate, GABA, and acetylcholine. Homeostasis ensures the proper balance of these neurotransmitters to facilitate efficient signal transmission between retinal neurons.
* **Synaptic plasticity:** Synapses, the junctions between neurons, exhibit plasticity, meaning they can adapt and change in response to activity and environmental cues. Retinal homeostasis involves mechanisms that regulate synaptic plasticity to optimize information flow and visual processing.

**Blood Flow and Metabolism:**

* **Regulation of retinal blood flow:** The retina requires a constant supply of oxygen and nutrients delivered by blood vessels. Retinal homeostasis ensures adequate blood flow to meet the metabolic demands of the retina.
* **Metabolic balance:** Retinal homeostasis maintains a delicate balance of metabolic processes, including glucose metabolism, oxygen utilization, and the production of ATP (cellular energy).

**Factors Affecting Retinal Homeostasis:**

* **Age:** As we age, the retina becomes more vulnerable to damage and dysfunction.
* **Light exposure:** Excessive light exposure can damage photoreceptors and lead to retinal degeneration.
* **Oxidative stress:** Oxidative stress, a condition caused by an imbalance between free radicals and antioxidants, can contribute to retinal damage.
* **Diabetes:** Diabetes can impair retinal blood flow and lead to diabetic retinopathy, a major cause of blindness.
* **Genetic factors:** Certain genetic mutations can increase the risk of retinal disorders.

**Maintaining Retinal Homeostasis:**

* **Healthy diet:** Consuming a diet rich in antioxidants, omega-3 fatty acids, and other essential nutrients can support retinal health.
* **Regular eye exams:** Regular eye exams are crucial for early detection and management of retinal disorders.
* **Protecting eyes from light:** Wearing sunglasses and avoiding prolonged exposure to bright light can protect the retina from damage.
* **Controlling blood sugar levels:** Maintaining proper blood sugar control is essential for preventing diabetic retinopathy.
* **Managing underlying health conditions:** Addressing any underlying health conditions that may affect retinal health is important.

Retinal homeostasis is a complex and dynamic process that is essential for maintaining healthy vision. Understanding this process and its underlying mechanisms is critical for developing effective treatments and strategies to prevent retinal disorders.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Sodium/nucleoside cotransporter 2A sodium/nucleoside cotransporter 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43868]Homo sapiens (human)
Sodium/potassium-transporting ATPase subunit beta-2A sodium/potassium-transporting ATPase subunit beta-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P14415]Homo sapiens (human)
Superoxide dismutase [Cu-Zn]A superoxide dismutase [Cu-Zn] that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00441]Homo sapiens (human)

Compounds (19)

CompoundDefinitionClassesRoles
lansoprazoleLansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.benzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
omeprazole5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
pantoprazolepantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
aromatic ether;
benzimidazoles;
organofluorine compound;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
environmental contaminant;
xenobiotic
floxuridinefloxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
uridineuridinesdrug metabolite;
fundamental metabolite;
human metabolite
phlorhizinaryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative
antioxidant;
plant metabolite
adenosinequinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlitadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
formylmethionyl-leucyl-phenylalanine methyl esterpeptide
rostafuroxinrostafuroxin: structure in first source
tecadenosontecadenoson: an A1 adenosine receptor agonist
ouabaincardiac glycoside : Steroid lactones containing sugar residues that act on the contractile force of the cardiac muscles.

ouabain : A steroid hormone that is a multi-hydroxylated alpha-L-rhamnosyl cardenoloide. It binds to and inhibits the plasma membrane Na(+)/K(+)-ATPase (sodium pump). It has been isolated naturally from Strophanthus gratus.

Ouabain: A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE.
11alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone
anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
digitoxindigitoxin : A cardenolide glycoside in which the 3beta-hydroxy group of digitoxigenin carries a 2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl trisaccharide chain.

Digitoxin: A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665)
cardenolide glycosideEC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
7,8,3'-trihydroxyflavone7,8,3'-trihydroxyflavone: a potent small molecule TrkB receptor agonist that protects spiral ganglion neurons from degeneration both in vitro and in vivo
digoxindigoxin : A cardenolide glycoside that is digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small.

Digoxin: A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
cardenolide glycoside;
steroid saponin
anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
digitoxigenindigitoxigenin : A 5beta-cardenolide that is 5beta-cardanolide with hydroxy substituents at the 3beta- and 14beta-positions and double bond unsaturation at C(20)-C(22).

Digitoxigenin: 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin.
14beta-hydroxy steroid;
3beta-hydroxy steroid
phakellistatin 2phakellistatin 2: isolated from the marine sponge Phakellia carteri; structure in first source
digitoxigenin monodigitoxosidedigitoxigenin monodigitoxoside: RN given refers to (ribo-3beta,5beta)-isomer
evomonosideevomonoside : A cardenolide glycoside consisting of digitoxigenin having an alpha-L-rhamnosyl moiety attached at the O(3)-position.

evomonoside: a cytotoxic cardiac glycoside from Lepidium apetalum; RN refers to (3beta,5beta)-isomer
cardenolide glycoside
halisulfate 1halisulfate 1: an isocitrate lyase inhibitor sesterterpene sulfate from sponge, Hippospongia sp.; structure in first sourceorganic molecular entitymetabolite